1-11 of 11
Xavier C. Badoux, MBBS
Close
Sort by
Journal Articles

Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): 1-Year Disease-Free Survival (DFS) Results From the MRD Cohort of the Phase 2 CAPTIVATE Study

William G. Wierda, MD PhD, Constantine S. Tam, MD, John N. Allan, MD, Tanya Siddiqi, MD, Thomas J. Kipps, MD PhD, Stephen Opat, FRACP, FRCPA, MBBS, Alessandra Tedeschi, MD, Xavier C. Badoux, MBBS, FRACP, FRCPA, Bryone J. Kuss, MBBS, PhD FRACP, FRCPA, Sharon Jackson, MD, Carol Moreno, MD PhD, Ryan Jacobs, MD, John M. Pagel, MD PhD, Ian W. Flinn, MD PhD, Cathy Zhou, MS, Edith Szafer-Glusman, PhD, Joi Ninomoto, PharmD, James P. Dean, MD PhD, Danelle F. James, MD MAS, Paolo Ghia, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-134446
Published: 2020
Journal Articles

Ibrutinib (Ibr) Plus Venetoclax (Ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Results from the MRD Cohort of the Phase 2 CAPTIVATE Study

Constantine S. Tam, MBBS, MD, Tanya Siddiqi, MD, John N. Allan, MD, Thomas J. Kipps, MD PhD, Ian W. Flinn, MD PhD, Bryone J. Kuss, MBBS, PhD FRACP, FRCPA, Stephen Opat, Paul M. Barr, MD, Alessandra Tedeschi, MD, Ryan Jacobs, MD, Xavier C. Badoux, MBBS, FRACP, FRCPA, Paolo Ghia, MD PhD, Juthamas Sukbuntherng, PhD, Ahmed Hamed Salem, PhD FCP, Kristin Russell, BS, Karl Eckert, BA, Cathy Zhou, MS, Joi Ninomoto, PharmD, Danelle F. James, MD MAS, William G. Wierda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 35.
https://doi.org/10.1182/blood-2019-121424
Published: 2019
Journal Articles

Increasing Cross-Referral and Recruitment to Clinical Trials: A New Approach

Roslyn Ristuccia, BSc MMedSc, Xavier C Badoux, MBBS, Melinda Gibson, BAppS MHSc, Admir Huseincehajic, BSc, Judith Trotman, MBChB
Journal: Blood
Blood (2015) 126 (23): 636.
https://doi.org/10.1182/blood.V126.23.636.636
Published: 2015
Journal Articles

Non-Inferior Pharmacokinetics with Comparable Safety and Response Rates for Subcutaneous (SC), Compared with Intravenous (IV), Rituximab in Combination with Fludarabine and Cyclophosphamide (FC) in Patients (Pts) with Untreated Chronic Lymphocytic Leukemia (CLL): Part 2 of the Phase Ib SAWYER Study (BO25341)

Sarit Assouline, MD MSc, Valeria Buccheri, MD PhD, Alain Delmer, MD, Gianluca Gaidano, MD PhD, Michael Brewster, BSc, Olivier Catalani, Sai Li, MD PhD, Christine McIntyre, PhD, Pakeeza Sayyed, PhD, Xavier C Badoux, MBBS
Journal: Blood
Blood (2014) 124 (21): 1995.
https://doi.org/10.1182/blood.V124.21.1995.1995
Published: 2014
Journal Articles

Long-Lasting Responses with Lenalidomide As Initial Therapy of Elderly Patients with Chronic Lymphocytic Leukemia (CLL)

Paolo Strati, Michael J. Keating, MD, William G. Wierda, MD, PhD, Xavier C. Badoux, MBBS, Steliana Calin, MD, James M. Reuben, PhD, Susan M. O'Brien, MD, Steven M. Kornblau, MD, Hagop M. Kantarjian, MD, Bang-Ning Lee, PhD, PA-C, Alessandra Ferrajoli, M.D.
Journal: Blood
Blood (2012) 120 (21): 3932.
https://doi.org/10.1182/blood.V120.21.3932.3932
Published: 2012
Journal Articles

Final Analysis of a Phase 2 Study of Lenalidomide and Rituximab in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Xavier C Badoux, MBBS, Michael J Keating, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Stefan Faderl, MD, Zeev Estrov, Manolo Pasia, BSN, Susan Lerner, MS, BA, Rachel L Sargent, MD, Hagop M. Kantarjian, MD, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2011) 118 (21): 980.
https://doi.org/10.1182/blood.V118.21.980.980
Published: 2011
Journal Articles

Patients with Relapsed CLL and 17p Deletion by FISH Have Very Poor Survival Outcomes.

Xavier C. Badoux, MBBS, Michael Keating, MD, Susan O'Brien, MD, Alessandra Ferrajoli, MD, Jan A. Burger, MD, PhD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, Tapan Kadia, MD, Lynne V Abruzzo, MD, PhD, William G. Wierda, M.D., Ph.D
Journal: Blood
Blood (2009) 114 (22): 1248.
https://doi.org/10.1182/blood.V114.22.1248.1248
Published: 2009
Journal Articles

Combination Therapy with Lenalidomide and Rituximab in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL).

Alessandra Ferrajoli, MD, Xavier C. Badoux, MBBS, Susan O'Brien, MD, William G. Wierda, MD, PhD, Stefan Faderl, MD, Zeev Estrov, MD, Manolo Pasia, RN, Bang-Ning Lee, PhD, James M. Reuben, PhD, Hagop Kantarjian, MD, Michael Keating, MD
Journal: Blood
Blood (2009) 114 (22): 206.
https://doi.org/10.1182/blood.V114.22.206.206
Published: 2009
Journal Articles

Cross-Talk Between CLL Cells and Endothelial Cells in the Bone Marrow Microenvironment: Role of Signal Transducer and Activator of Transcription (Stat)-3.

Xavier C. Badoux, MBBS, Carlos Bueso Ramos, MD, PhD, David Harris, B.S., Ping Li, Ph.D., Zhiming Liu, B.S., Jan Burger, M.D., Susan O'Brien, MD, Alessandra Ferrajoli, MD., Michael Keating, MD, Zeev Estrov, MD
Journal: Blood
Blood (2009) 114 (22): 1242.
https://doi.org/10.1182/blood.V114.22.1242.1242
Published: 2009
Journal Articles

Chemoimmunotherapy with Cyclophosphomide, Fludarabine, Alemtuzumab and Rituximab (CFAR) Is Effective in Relapsed Patients with Chronic Lymphocytic Leukemia (CLL).

Xavier C. Badoux, MBBS, Michael Keating, MD, Susan O'Brien, MD, Tapan Kadia, MD, Alessandra Ferrajoli, MD., Stefan Faderl, MD, Charles Koller, MD, Guillermo Garcia-Manero, MD, Jan A. Burger, MD, PhD, William G. Wierda, M.D., Ph.D,
Journal: Blood
Blood (2009) 114 (22): 3431.
https://doi.org/10.1182/blood.V114.22.3431.3431
Published: 2009
Journal Articles

Pretreatment Factors Associated with Second Malignancies Occuring After Frontline Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Patients with Chronic Lymphocytic Leukemia (CLL).

Nicolas Batty, MD, Xavier C. Badoux, MBBS, Michael Keating, MD, E. Lin, Susan Lerner, M.S., RHIA, Susan O'Brien, Alessandra Ferrajoli, MD., Tapan Kadia, MD, Jan A. Burger, MD, PhD, Stefan Faderl, MD, William G. Wierda, M.D., Ph.D
Journal: Blood
Blood (2009) 114 (22): 3448.
https://doi.org/10.1182/blood.V114.22.3448.3448
Published: 2009